Weitere ähnliche Inhalte Kürzlich hochgeladen (20) 2. It not only leads to dose reduction or discontinuation of
treatment but also decreases the quality of life of cancer
survivors.
With the exception of paclitaxel
and oxaliplatin, which causes an
acute neuropathy that emerges
either during or shortly after
infusion, the onset of CIPN is
usually delayed and appears to
depend on the total cumulative
dose.
Chemotherapy-Induced Peripheral
Neuropathy (CIPN) is a frequent,
dose-dependent complication of
anticancer drugs, including
platinums, taxanes, epothilones,
vinca alkaloids, and newer agents,
such as bortezomib.
INTRODUCTION
Delveinsight © 2018 | All rights re
4. MARKET SIZE
Owing to the launch of
promising therapies, market
size is expected to
increase in the G8, during
the forecast period (2018-
2027)
The market size of currently
prescribed offlabel therapies for the
treatment of CIPN is expected to
initially experience steady growth, and
will further decrease owing to the
launch of upcoming therapies in
forecast period [2018-2027]
Companies are focused on the
development of targeted
therapies for the treatment of
CIPN, which are expected to
create an evident impact on the
market revenue in coming years
The assessment of CIPN
is not standardized and
thus acts as a restraint in
the therapeutic
market of this indication.
01
02
05
04
03
Expected launch of SP-04 (Solasia),
Tetrodotoxin (WEX
Pharmaceuticals), and E-52862
(Esteve) during the forecast period
(2018-2027) may create a positive
impact on the CIPN market
Delveinsight © 2018 | All rights re
5. EMERGING DRUGS AND COMPANIES
1
2
3
4
5
Tetrodotoxin
WEX
Pharmaceuticals
MN - 166
NIAGENMedicinova
Chroma Dex
KRN 5500
DARA
Biosciences
Lpathomab
Apollo
Endosurgery
DRUGS
Delveinsight © 2018 | All rights re
6. DelveInsight, market
research and consulting
firm, provides end to
end comprehensive
solutions to the Life
Science Industry
We help our customers
in best decision making
through our expertise
in research & analysis
and comes out with
unmatched data &
forecasts
“insight across the
value chain” to help
organizations make
important business
decisions through the
use and analysis of
actionable market
intelligence
To be the most trusted
marketing research
firm & business
consulting firm world
wide. To be a renowned
and premier data
driven solution
providers among
Pharma & Biotech
companies
ABOUT
0
1
MISSION
0
2
VISION
0
3
ABOUT DELVEINSIGHT
Delveinsight © 2018 | All rights re
7. SERVICES OFFERED BY DELVEINSIGHT
Opportunity
Assessment
5
Report Store6
Socialytics7
Competitive
Analysis
8
Consulting 1
Market
Intelligence
2
Pipeline 3
Forecasting 4
Delveinsight © 2018 | All rights re
